Your session is about to expire
← Back to Search
Education & Empowerment for Breast Cancer Screening Compliance
N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights
Study Summary
This trial will compare long-term effects of interventions by studying how well guidelines for initial and repeat breast cancer screenings are followed.
Who is the study for?
This trial is for Latina women aged 50-74 who have not had a mammogram in the past two years and have no personal history of breast cancer. They should not have volunteered in health studies before, nor be enrolled in certain parts of this study.Check my eligibility
What is being tested?
The study tests how education and empowerment strategies affect Latinas' adherence to recommended breast cancer screenings. It uses social network analysis and implementation science within a randomized clinical trial to compare long-term effects.See study design
What are the potential side effects?
Since the interventions involve education and empowerment rather than medical treatments, traditional physical side effects are not expected. However, participants may experience increased stress or anxiety related to screening outcomes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Network members in the empowerment arm will be more likely to obtain guideline-concordant initial and repeat BC screening than network members in the educate arm
Non-adherent Latinas greater BC knowledge and stronger motivation to be a role model will mediate the greater BC screening rates among non-adherent Latinas in the empower arm relative to the educate arm
Non-adherent Latinas in the empowerment arm are more likely to obtain initial and repeat BC screening than non-adherent Latinas in the education arem
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Empower (Empowerment + Navigation) SessionsExperimental Treatment1 Intervention
Session 1 BC knowledge, BC disparities, USPSTF guidelines, barriers and preferred solutions to BC screening CHW testimonials, Empirical data, Individual action plans for BC screening Sessions 2 & 3 BC screening as leading by example, BC promotion strategies that reflect personal and network members' preferences, opportunities to volunteer/be a part of tight-knit initiatives, partnerships with navigators/CHWs to serve as "bridges" for network members CHW testimonials , resource guides for BC promotion, individual action plans for promoting BC, role playing activities (session 2) Participant testimonials, participant relays empirical data, group discussion and plans for promoting BC (session 3)
Group II: Educate (Education + Navigation) SessionsExperimental Treatment1 Intervention
Session 1 BC knowledge, BC disparities, USPSTF guidelines, barriers and preferred solutions to BC screening, Community Health Workers (CHW) testimonials, empirical data, individual action plans for BC screening Session 2 &3 Health knowledge (diet and physical activity guidelines), barriers and preferred solutions to dietary and physical activity change, CHW testimonials, empirical data, individual action plans for diet
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
609 Previous Clinical Trials
1,558,909 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Empower (Empowerment + Navigation) Sessions
- Group 2: Educate (Education + Navigation) Sessions
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical experiment include participants who are older than sixty?
"Those aged 18 to 74 years of age are eligible for enrolment in this trial."
Answered by AI
What is the current scope of this experiment in terms of participants?
"Affirmative. The clinicaltrials.gov page for this trial reveals that recruitment is still open, with an initial posting on March 14th 2023 and a most recent update occurring on May 3rd 2021. This study requires 400 patients to be enrolled at two distinct medical sites."
Answered by AI
Are there any openings left in this experiment?
"Data on clinicaltrials.gov demonstrates that this trial is actively seeking enrolment, having been posted on March 14th 2023 and recently updated on May 3rd of the same year."
Answered by AI
Do I meet the criteria to participate in this trial?
"Patients with a history of breast cancer screening can qualify for this clinical trial, assuming they are within the age range 18 to 74. 400 individuals in total will be admitted into this research project."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger